Nhoa SA
OTC:ENGPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nhoa SA
OTC:ENGPF
|
FR |
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKD
|
JP |
|
P
|
Perenti Ltd
XMUN:FWG
|
AU |
|
C
|
Ctac NV
AEX:CTAC
|
NL |
|
W
|
Wang On Group Ltd
F:WON1
|
HK |
|
Nedap NV
AEX:NEDAP
|
NL |
|
Corbus Pharmaceuticals Holdings Inc
F:3371
|
US |
|
M
|
Major Cineplex Group PCL
SET:MAJOR
|
TH |
|
F
|
FFI Holdings Ltd
ASX:FFI
|
AU |
|
P
|
Prolexus Bhd
KLSE:TECHBASE
|
MY |
|
A
|
Amrest Holdings SE
XMUN:1QT
|
ES |
|
Y
|
Yeti Holdings Inc
F:1YN
|
US |
|
N
|
NK Lukoil PAO
F:LUK
|
RU |
|
A
|
Adecoagro SA
SWB:ACD
|
LU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ENGPF's stock price target?
Not Available
ENGPF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nhoa SA?
Projected CAGR
53%
Over the last 6 years, the compound annual growth rate for Revenue has been 74%. The projected CAGR for the next 3 years is 53%.